These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 28495231)
21. Reliability of administrative data for the identification of Parkinson's disease cohorts. Baldacci F; Policardo L; Rossi S; Ulivelli M; Ramat S; Grassi E; Palumbo P; Giovannelli F; Cincotta M; Ceravolo R; Sorbi S; Francesconi P; Bonuccelli U Neurol Sci; 2015 May; 36(5):783-6. PubMed ID: 25663085 [TBL] [Abstract][Full Text] [Related]
22. Impact of nursing home admission on health care use and disease status elderly dependent people one year before and one year after skilled nursing home admission based on 2012-2013 SNIIRAM data. Atramont A; Bourdel-Marchasson I; Bonnet-Zamponi D; Tangre I; Fagot-Campagna A; Tuppin P BMC Health Serv Res; 2017 Sep; 17(1):667. PubMed ID: 28923106 [TBL] [Abstract][Full Text] [Related]
24. A cohort study of therapeutic prescriptions after the end of phytotherapy drug reimbursement by French Social Security. Riou França L; Vidal C; Bourechak N; Jeunne PL; Deville GS; Massol J Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):760-8. PubMed ID: 23208799 [TBL] [Abstract][Full Text] [Related]
25. Regional trends and the impact of various patient and hospital factors on outcomes and costs of hospitalization between academic and nonacademic centers after deep brain stimulation surgery for Parkinson's disease: a United States Nationwide Inpatient Sample analysis from 2006 to 2010. Sharma M; Ambekar S; Guthikonda B; Wilden J; Nanda A Neurosurg Focus; 2013 Nov; 35(5):E2. PubMed ID: 24175862 [TBL] [Abstract][Full Text] [Related]
26. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa]. Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232 [TBL] [Abstract][Full Text] [Related]
27. The epidemiology of Parkinson's disease in the Italian region Friuli Venezia Giulia: a population-based study with administrative data. Valent F; Devigili G; Rinaldo S; Del Zotto S; Tullio A; Eleopra R Neurol Sci; 2018 Apr; 39(4):699-704. PubMed ID: 29427166 [TBL] [Abstract][Full Text] [Related]
28. Comparison of chronic analgesic drugs prevalence in Parkinson's disease, other chronic diseases and the general population. Brefel-Courbon C; Grolleau S; Thalamas C; Bourrel R; Allaria-Lapierre V; Loï R; Micallef-Roll J; Lapeyre-Mestre M Pain; 2009 Jan; 141(1-2):14-8. PubMed ID: 19062167 [TBL] [Abstract][Full Text] [Related]
29. [Evaluation of surgical practice in the treatment of lung cancer in France from the PMSI national database]. Bernard A; Pagès PB; Mariet AS; Pforr A; Cottenet J; Quantin C Rev Mal Respir; 2019 Jan; 36(1):31-38. PubMed ID: 30287109 [TBL] [Abstract][Full Text] [Related]
30. Cohort of one million patients initiating antidepressant treatment in France: 12-month follow-up. Fagot JP; Cuerq A; Samson S; Fagot-Campagna A Int J Clin Pract; 2016 Sep; 70(9):744-51. PubMed ID: 27484351 [TBL] [Abstract][Full Text] [Related]
31. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease. Perez-Lloret S; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Meissner WG; Schelosky L; Tison F; Rascol O JAMA Neurol; 2014 Jul; 71(7):884-90. PubMed ID: 24839938 [TBL] [Abstract][Full Text] [Related]
32. Projections of prevalence, lifetime risk, and life expectancy of Parkinson's disease (2010-2030) in France. Wanneveich M; Moisan F; Jacqmin-Gadda H; Elbaz A; Joly P Mov Disord; 2018 Sep; 33(9):1449-1455. PubMed ID: 30145805 [TBL] [Abstract][Full Text] [Related]
33. Clinical Complexity and Use of Antipsychotics and Restraints in Long-Term Care Residents with Parkinson's Disease. Heckman GA; Crizzle AM; Chen J; Pringsheim T; Jette N; Kergoat MJ; Eckel L; Hirdes JP J Parkinsons Dis; 2017; 7(1):103-115. PubMed ID: 27689617 [TBL] [Abstract][Full Text] [Related]
34. The current and projected economic burden of Parkinson's disease in the United States. Kowal SL; Dall TM; Chakrabarti R; Storm MV; Jain A Mov Disord; 2013 Mar; 28(3):311-8. PubMed ID: 23436720 [TBL] [Abstract][Full Text] [Related]
35. [Alzheimer disease and other dementia in France: Identification, management and neuroleptic use (2007-2009)]. Tuppin P; Cuerq A; Weill A; Ricordeau P; Allemand H Rev Neurol (Paris); 2012 Feb; 168(2):152-60. PubMed ID: 22104062 [TBL] [Abstract][Full Text] [Related]
36. [The estimation of prevalence of Parkinson disease in Navarra. An epidemiological study of the consumption of anti-parkinsonian drugs]. Artázcoz Sanz MT; Viñes Rueda JJ Rev Esp Salud Publica; 1995; 69(6):479-85. PubMed ID: 8789360 [TBL] [Abstract][Full Text] [Related]
37. Joint use of epidemiological and hospital medico-administrative data to estimate prevalence. Application to French data on breast cancer. Colonna M; Mitton N; Schott AM; Remontet L; Olive F; Gomez F; Iwaz J; Polazzi S; Bossard N; Trombert B Cancer Epidemiol; 2012 Apr; 36(2):116-21. PubMed ID: 22204835 [TBL] [Abstract][Full Text] [Related]
38. The increasing prevalence of Parkinson's disease in Estonia. Kadastik-Eerme L; Taba N; Asser T; Taba P Acta Neurol Scand; 2018 Sep; 138(3):251-258. PubMed ID: 29707760 [TBL] [Abstract][Full Text] [Related]
39. Homeopathy in France in 2011-2012 according to reimbursements in the French national health insurance database (SNIIRAM). Piolot M; Fagot JP; Rivière S; Fagot-Campagna A; Debeugny G; Couzigou P; Alla F Fam Pract; 2015 Aug; 32(4):442-8. PubMed ID: 25921648 [TBL] [Abstract][Full Text] [Related]
40. Incidence and prevalence of Parkinson's disease in the Italian region of Umbria: a population-based study using healthcare administrative databases. Eusebi P; Franchini D; De Giorgi M; Abraha I; Montedori A; Casucci P; Calabresi P; Tambasco N Neurol Sci; 2019 Aug; 40(8):1709-1712. PubMed ID: 30945089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]